International scoring system for evaluating prognosis in myelodysplastic syndromes

Blood

Volumn 89, Issue 6, 1997, Pages 2079-2088

  Greenberg, Peter ^a   Cox, Christopher ^b   LeBeau, Michelle M ^b   Fenaux, Pierre ^b   Morel, Pierre ^b   Sanz, Guillermo ^b   Sanz, Miguel ^b   Vallespi, Teresa ^b   Hamblin, Terry ^b   Oscier, David ^b   Ohyashiki, Kazuma ^b   Toyama, Keisuke ^b   Aul, Carlo ^b   Mufti, Ghulam ^b   Bennett, John ^b  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; BONE MARROW EXAMINATION; CHROMOSOME 20Q; CHROMOSOME 5Q; CHROMOSOME 7; CHROMOSOME ABERRATION; CHROMOSOME DELETION; CLINICAL FEATURE; CYTOGENETICS; DEMOGRAPHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SCORING SYSTEM; SURVIVAL;

EID: 0030897009     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.6.2079     Document Type: Article

References (31)

1. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C: Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 51:189, 1982
2. Mufti GJ, Stevens JR, Oscier DG, Hamblin TJ, Machin D: Myelodysplastic syndromes: A scoring system with prognostic significance. Br J Haematol 59:425, 1985
3. Sanz GF, Sanz MA, Vallespi T, Canizo M: Two regression models and a scoring system for predicting survival and planning treatment in myelodysplastic syndromes: A multivariate analysis of prognostic factors in 370 patients. Blood 74:395, 1989
4. Aul C, Gatterman N, Heyll A, Germing U: Primary myelodysplastic syndromes: Analysis of prognostic factors in 235 patients and proposals for an improved scoring system. Leukemia 6:52, 1992
5. Morel P, Hebbar M, Lai JL, Duhamel A: Cytogenetic analysis has strong prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system: A report on 408 cases. Leukemia 7:1315, 1993
6. Toyama K, Ohyashiki K, Yoshida Y, Abe T: Clinical implications of chromosomal abnormalities in 401 patients with MDS: A multicentric study in Japan. Leukemia 7:499, 1993
7. Oscier D: Myelodysplastic syndromes. Ballieres Clin Haematol 1:389, 1987
8. Tricot G, Boogaerts MA, De Wolf-Peeters C, van den Berghe H, Verwilghen RL: The myelodysplastic syndromes: Different evolution patterns based on sequential morphological and cytogenetic investigations. Br J Haematol 59:659, 1985
9. Rios A, Canizo M, Sanz M, Vallespi T, Sanz G, Torrabella M, Gomis F, Ruiz C, San Miguel J; Bone marrow biopsy in myelodysplastic syndromes: Morphological characteristics and contribution to the study of prognostic factors. Br J Haematol 75:26, 1990
10. Jacobs RA, Cornbleet M, Vardiman J, Larson R, LeBeau MM, Rowley JD: Prognostic implications of morphology and karyotype in primary myelodysplastic syndromes. Blood 67:1765, 1986
11. Yunis JJ, Lobell M, Arnesen MA, Oken MM, Mayer MG, Rydell RE, Brunning RD: Refined chromosome study helps define prognostic subgroups in most patients with primary myelodysplastic syndrome and acute myelogenous leukaemia. Br J Haematol 68:189, 1988
12. Pierre R, Catovsky D, Mufti G, Swansbury G: Clinical cytogenetic correlations in myelodysplasia (preleukemia). Cancer Genet Cytogenet 44:15, 1990
13. Greenberg P, Taylor K, Larson R, Koeffler P, Negrin R, Saba H, Ganser A, Jakubowski A, Gabrilove J, Mufti G, Cruz J, Hammond W, Broudy V, Langley GR, Keating A, Vardiman J, Lamborn K, Brown S: Phase III randomized multicenter trial of G-CSF vs. observation for myelodyplastic syndromes. Blood 82:196a, 1993 (abstr, suppl 1)
14. Bennett JM, Catovsky D, Daniel MT, Flandrin G. Galton D, Gralnick H, Sultan C, Cox C: The chronic myeloid leukemias: Guidelines for distinguishing chronic granulocytic, atypical chronic myeloid, and chronic myelomonocytic leukemia. Br J Haematol 87:746, 1994
15. Mitelman F (ed): ISCN (1995): An International System for Human Cytogenetic Nomenclature. Basel, Switzerland, Karger, 1995
16. Coiffier B, Adeleine P, Viala JJ, Byron P: Dysmyelopoietic syndromes: A search for prognostic factors in 193 patients. Cancer 52:83, 1983
17. Tricot G, Vlietinck R, Boogaerts MA, Hendrickx B: Prognostic factors in the myelodysplastic syndromes: Importance of initial data on peripheral blood counts, bone marrow cytology, trephine biopsy and chromosomal analysis. Br J Haematol 60:19, 1985
18. Vallespi T, Torrabadella M, Julia A, Irriguible D: A study of 101 cases according to the FAB classification. Br J Haematol 61:83, 1985
19. Kerkhofs H, Hermans J, Haak HL, Leeksma C: Utility of the FAB classification for myelodysplastic syndromes: Investigation of prognostic factors in 237 cases. Br J Haematol 65:73, 1987
20. Greenberg PL: The myelodysplastic syndromes, in Hoffman R, Benz E, Shattil S, Furie B, Cohen H, (eds): Hematology: Basic Principles and Practice (ed 2). New York, NY, Churchill Living-stone, 1994, p 1113
21. Foucar K, Langdon RM, Armitage JO, Olson D, Carroll TJ Jr: Myelodysplastic syndromes: A clinical and pathologic analysis of 109 cases. Cancer 56:553, 1985
22. Wattel E, Lai JL, Hebbar M, Preudhomme C: De novo myelodysplastic syndrome with deletion of the long arm of chromosome 20: A subtype of MDS with distinct hematological and prognostic features? Leuk Res 17:921, 1993
23. Campbell LJ, Garson OM: The prognostic significance of deletion of the long arm of chromosome 20 in myeloid disorders. Leukemia 8:67, 1994
24. Sokal G, Michaux JL, van den Berghe H, Cordier A, Rodhain J, Ferrantr A, Moriau M, De Bruyere M, Sonnet J: A new hematologic syndrome with a distinct karyotype: The 5q-chromosome. Blood 46:519, 1975
25. Van den Berghe H, Vermaelen K, Mecucci C, Barbieri D, Tricot G: The 5q-anomaly. Cancer Genet Cytogenet 17:189, 1985
26. United Kingdom Cytogenetics Group: Loss of the Y chromosome from normal and neoplastic bone marrows. Genes Chromosome Cancer 5:83, 1992
27. Samuels BL, Larson RL, LeBeau MM, Daly KM, Bitter MA, Vardiman JW, Barker CM, Rowley JD, Golomb HM: Specific chromosomal abnormalities in acute nonlymphocytic leukemia correlate with drug susceptibility-in vivo. Leukemia 2:79, 1988
28. Suzman R, Kinsella K, Myers G: Demography of older populations in developed countries, in Evans JG, Williams TF (eds): Oxford Textbook of Geriatric Medicine. New York, NY, Oxford University, 1992, p 3
29. Morel P, Declercq C, Hebbar M, Bauters F, Fenaux P: Prognostic factors in myelodysplastic syndromes: Critical analysis of the impact of age and gender and failure to identify a very-low-risk group using standard mortality ratio techniques. Br J Haematol 94:116, 1996
30. Storniolo AM, Moloney WC, Rosenthal DS, Cox C, Bennett JM: Chronic myelomonocytic leukemia. Leukemia 4:766, 1990
31. Fenaux P, Benscart R, Lai J, Jouet J, Bauters F: Prognostic factors in adult chronic myelomonocytic leukemia. Analysis of 107 cases. J Clin Oncol 6:1417, 1990